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135cc (range, 228-630) respectively. The treatment plan was designed 
to deliver a dose of 50.0 Gy to the planning target volume at 2 Gy-
daily fractions, 5 days a week. The objective for the plans was the 
coverage of 95% of the PTV with the prescribed dose. Planning 
Objectives were placed to ensure that no more than 1% of the PTV 
will receive more than 107%.Planning objectives were also placed for 
normal structures as per the hospital protocol. Dose-volume 
histograms (DVH) for the target volume and the organs at risk (Small 
bowel,bladder, femoral heads, Rectum and healthy tissue) were 
compared for the 2 different techniques. Monitor units (MU) and 
delivery treatment time are also reported. 
Results: All plans achieved fulfilled objectives. Both IMRT and VMAT 
resulted in similar coverage of PTV. The difference between the doses 
to the normal structures for the two techniques was not significant. 
Conformity Factor (CF95%)for the PTV was 0.9778 ± 0.01 (VMAT), and 
0.9805 ± 0.013 (IMRT).Homogeneity Index (D5% - D95%/ D Pres) for PTV 
was 0.068 ± 0.01 for VMAT and 0.0596 ± 0.01 IMRT. 
Conclusions: For patients suffering from Carcinoma of Cervix, VMAT 
with 2 arcs was able to deliver equivalent treatment plan to IMRT in 
terms of PTV coverage with marginally inferior homogeneity Index. It 
provided a similar organ at risk sparing, reduced healthy tissue sparing 
(V5 and V10) and significant reductions of MU and treatment time per 
fraction with respect to IMRT. Factors like gamma index, reduction in 
delivery time and treatment monitor units are also discussed and 
reported. 
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Purpose/Objective: The purpose of this paper is to assess the 
importance of the variations in daily positioning in treatments of IMRT 
in head and neck cancer patients, in order to check whether PTVs 
margins are adequate. 
Materials and Methods: Ten consecutive head and neck patients with 
bilateral lymph nodes, previously treated with the integrated boost 
technique in 30 fractions (30 x 1.8 Gy to PTV1 and 30 x 2.25 Gy to 
PTV2), were recalculated using the same IMRT plan with a 5 mm 
displacement in all directions (longitudinal, lateral and vertical, 
positive and negative), which gives us a total of 60 cases. Variations in 
doses to both treatment volumes and organs at risk were evaluated, 
and for cases exceeding significative values, the same procedure was 
repeated with 3 mm displacements. 
Results: To assess the goodness of the results two parameters were 
used: the dose to the CTV2, considering invalid cases where the 
decrease in CTV2 volume coverage was greater than 1%, and the dose 
in the spinal cord, considering invalid those cases in which the volume 
receiving 50Gy exceeded 2cc. Thirteen of the sixty cases showed 
deviations greater than these values. In these cases the same 
procedure was repeated, now with deviations of 3 mm, and there 
were still two cases out of range. These two cases (patients 5 and 9) 
were recalculated with displacements of 2 mm in all directions, and 
there were no values out of range. 
  
Conclusions: We can conclude that with less or equal 2 mm 
displacement in any direction, IMRT treatments in patients with head 
and neck tumors are properly administered, and it is not necessary to 
correct the deviations up to 2 mm that can be observed in daily 
checks with the portal images. 
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Purpose/Objective: To investigate the feasibility of volumetric 
modulated arc therapy with SmartArc (VMAT-S) for endometrial 
cancer to achieve equivalent plan quality with higher delivery 
efficiency, against with intensity-modulated radiotherapy (IMRT) and 
helical tomotherapy (HT).  
Materials and Methods: Nine patients with endometrial cancer were 
retrospectively studied. Three plans were generated with VMAT-S, 
IMRT and HT for each patient. The dose distribution of planning target 
volume (PTV), organs at risk (OARs) and normal tissue were compared. 
The monitor units (MUs) and treatment delivery time were also 
evaluated. 
Results: The average homogeneity index was 1.06, 1.10 and 1.07 for 
VMAT-S, IMRT and HT plans. The V40 of rectum, bladder and pelvis 
bone decreased 9.0%, 3.0%, and 3.0% in VMAT-S compared with IMRT, 
respectively. The target coverage and OARs sparing were comparable 
between VMAT-S and HT. The average MU was 823, 1105 and 8403 for 
VMAT-S, IMRT and HT. The average delivery time was 2.6 minutes, 8.6 
minutes, and 9.5 minutes.  
Conclusions: VMAT-S provided comparable plan quality with 
significant shorter delivery time and less MUs compared with IMRT and 
HT for endometrial cancer. In addition, more homogeneous PTV 
coverage and superior OARs sparing in the medium to high dose region 
were observed in VMAT-S over IMRT.  
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Purpose/Objective: RT treatment-planning techniques may result in a 
uniform dose delivery to the PTV in prostate plans well within the 
homogeneity criteria as specified by the ICRU 83 (D98%> 95% and D2% < 
107%). However, increasing the inhomogeneity of the target dose to 
the PTV allows for a steeper dose gradient and subsequently reducing 
the dose delivery to the adjacent rectal wall and anal sphincter, and 
potentially reducing toxicity. 
Materials and Methods: A selection of 9 clinical prostate RT plans 
with substantial homogeneous target coverage was re-planned. For 
the new plans, conformity and OARs sparing were improved, at the 
cost of homogeneous target coverage. The inhomogeneity was kept 
within the ICRU 83 criteria. The target dose homogeneity in the PTV: 
HI=(D2%-D98%)/D50%, the parameter V64Gy for the rectal wall and the Dmean 
in the anal sphincter were determined. A comparison of these 
parameters is made between the original and the inhomogeneous 
plan. Additionally, the change in the underlying DVH-curves was 
monitored. 
Results: The homogeneity index in the PTV dose distribution HIPTV 
increased in all re-planned RT plans ranging from 51% to 105% 
compared to the original plan (HIorig avg=0.056, σ=0.006). The values of 
the parameters V64Gy for the rectal wall and Dmean for the anal 
sphincter decreased in all inhomogeneous plans. For the rectal wall 
the V64Gy parameter decreased down to -16%, and for the anal 
sphincter the Dmean decreased down to -7.6Gy, see figure. Out of the 9 
plans, 4 showed an overall drop of the DVH curve for the rectal wall, 
while the others showed some increase in the high dose regime. An 
increase in the inhomogeneity of the dose delivery to the PTV creates 
local hotspots, which is reason for concern when considering target 
position inaccuracy during treatment. 
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Figure shows the absolute change in the Dmean for the anal sphincter 
(left y-axis) and relative change in the V64Gy for the rectal wall (right 
y-axis) expressed as a function of the relative increase in the 
homogeneity index HI of the dose distribution in the PTV. 
Conclusions: By increasing the inhomogeneity of the targeted dose to 
the PTV in prostate RT plans the dose delivered to the rectal wall and 
anal sphincter, as measured by respectively the clinical relevant 
parameters V64Gy and Dmean, can be reduced considerably. 
   
 ELECTRONIC POSTER: PHYSICS TRACK: TREATMENT 
PLAN OPTIMISATION  
  
EP-1228   
Advantages and limitations of multi-criteria optimization (MCO) for 
prostate IMRT planning. 
C.K. McGarry1, R. Bokrantz2, J.M. O'Sullivan3, A.R. Hounsell1 
1Belfast Health and Social Care Trust, Radiotherapy Physics, Belfast, 
United Kingdom  
2KTH Royal Institute of Technology, Optimization and Systems Theory, 
Stockholm, Sweden  
3Queens University of Belfast, Centre for Cancer Research and Cell 
Biology, Belfast, United Kingdom  
 
Purpose/Objective: To validate multi-criteria optimization (MCO) in 
RayStation (v2.4, RaySearch Laboratories, Stockholm, Sweden) against 
standard intensity modulated radiation therapy (IMRT) optimization in 
Oncentra (v4.1, Nucletron BV, Veenendal, the Netherlands) and to 
characterise dose differences due to conversion of navigated MCO 
plans into deliverable leaf apertures.  
Materials and Methods: Step and shoot radiotherapy treatment plans 
were created for ten prostate cancer patients using either standard 
IMRT optimization or MCO. Pareto fronts of average rectal dose versus 
target homogeneity were computed for each patient case and 
planning technique. The standard IMRT plans were generated by 
direct step and shoot optimization. The weight for the rectum 
objective was incrementally altered to trade this criterion against 
homogeneity. The corresponding trade-off for the MCO plans managed 
through a user interface that permits continuous navigation between 
plans optimized with respect to fluence. Navigated plans were made 
deliverable at incremental steps along a trajectory between maximal 
homogeneity and maximal rectal sparing and exported to Oncentra 
where final dose was re-calculated. Plan quality was assessed by 
comparison of the clinically acceptable plan with minimal rectal dose 
generated by each planning technique. Dosimetric differences 
between navigated and deliverable MCO plans were also quantified. 
Results: MCO planning for all patient cases resulted in improved rectal 
sparing and superior target homogeneity compared to standard IMRT 
optimization. The improvements were, however, to some extent at 
the expense of less conformal dose distributions. The dose deviations 
due to conversion of the navigated to deliverable MCO plans increased 
as higher priority was placed on rectal avoidance. Discrepancies 
between final dose calculated by collapsed cone in RayStation and 
pencil beam in Oncentra were quantified and found to be minimal. 
Conclusions: Similar or better IMRT plans can be created for prostate 
cancer patients using MCO compared to standard IMRT optimization. 
Limitations exist within MCO regarding conversion of navigated plans 
to deliverable apertures, particularly for plans that emphasize 
avoidance of critical structures.  
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Purpose/Objective: Radiation dose is defined as energy deposited per 
unit mass (Gy = J/kg). If dose is multiplied by mass on a voxel-by-
voxel basis, and a summation over all voxels within a volume of 
interest (VOI) is performed, then the total energy imparted on that 
VOI would be obtained. Energy minimization approaches are 
commonly used in the solution of many physics problems. However, 
little attention has been paid to this fundamental approach for 
treatment plan optimization in radiotherapy. Here we present a 
framework for IMRT optimization based on total energy minimization, 
and make comparisons to the 'standard of care', realized through 
dose-volume-histogram-based (DVH)optimization. 
Materials and Methods: A DVH-based quadratic objective function is 
compared to a total energy minimization objective function. using a 
digital phantom-patient.The phantom is built from four 10x10x10 cm3 
cubical volumes of interest (VOIs). The central VOI has a density of 1.0 
g/cm3 and includes a cylindrical (3 cm in diameter, 3 cm in length) 
target (PTV). The other three VOIs form (on top and two sides of the 
central cube) an organ at risk (OAR) with three different densities: 0.8 
(OAR0.8), 0.2 (OAR0.2),and 0.5 (OAR0.5) g/cm3. Two sets of deliverable 
plans are generated with DVH- and energy-based optimization 
schemes: a) a 2-beam plan with 2 IMRT segments, and b) a 3-beam 
plan with 3 IMRT segments. In the 2-beam plan the PTV is irradiated 
with an AP beam through OAR0.8 and an orthogonal beam through 
OAR0.2. In the 3-beam plan an additional orthogonal beam through 
OAR0.5 is added. DVH and energy optimizations were performed for 
both sets of plans, aiming to deliver a 100 cGy to 95% of the PTV, 
while minimizing the dose to the OAR as much as possible. 
Results: The mean, the integral, and the coverage doses, as well as 
the MUs to the OAR and the PTV from DVH- and energy-optimized 2- 
and 3-beam plans are summarized in the table below. For comparable 
PTV coverage,the energy optimized plan in the 2-beam case results in 
lower OAR dose by 8.6%,while the deposited energy to the OAR is 
lower by 18.5%. Similarly, in the 3-beam scenario the energy 
optimized plan results in mean and integral dose reduction to the OAR 
by 9.8% and 26% respectively. The plan MUs in the 2- and 3-beam 
scenarios differ by less than 2%. 
 2-beam/2-segment 
plan 
(OAR0.8 + OAR0.2) 
3-beam/3-segment 
plan 
(OAR0.8 + OAR0.2 + 
OAR0.5) 
DVH Energy DVH Energy 
PTV D95 [cGy] 100 100 100 100 
Mean Dose OAR
[cGy] 
11.4 10.5 10.1 9.2 
Integral Dose OAR
[J] 
0.109 0.092 0.155 0.123 
MUs 153 156 161 159 
 
Conclusions: In a heterogeneous media total energy minimization and 
DVH-based inverse optimization differ for the simplest setup of 2 and 
3 orthogonal beam IMRT plans, with 2 and 3 segments respectively. 
The reported findings are for IMRT plans, where the fluence maps are 
converted to MLC step-and-shoot leaf trajectories, and therefore the 
computed doses are from actual deliverable plans. For an equivalent 
PTV coverage the average doses to surrounding critical structures, 
intended to be spared, are lower by almost~10% with energy 
optimization. Energy optimization resulted in even more dramatic 
reduction of the integral dose in excess of 20%.  
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Purpose/Objective: Recent research has shown that the optimization 
model hitherto used in HDR brachytherapy correspond weakly to the 
dosimetric indices used to evaluate the quality of a dose distribution. 
Alternative models that include such dosimetric indices explicitly have 
been presented; however including the dosimetric indices explicitly 
yields intractable models that cannot be solved to optimality. We will 
present an alternative approach. 
Materials and Methods: We use surrogates to the dosimetric indices 
based on applying the concept of conditional value-at-risk to the dose-
volume-histogram (DVH), instead of the exact indices. This yields a 
linear model that is easy to solve to optimality, and where constraints 
are easy to interpret and modify to obtain satisfactory dose 
distributions. 
Results: We show by experimental comparisons that our proposed 
model corresponds well with the dosimetric indices and that the 
quality of generated dose distributions is equivalent to those 
generated by the standard model. 
Conclusions: Our proposed model is a viable surrogate to optimizing 
dosimetric indices that quickly and easily yields high quality dose 
distributions and is more intuitive and easier to steer for the phycisist 
than current penality based models 
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